Top Clinical Trials Startups in 2026

TrialSpark is transforming the way new medical treatments are brought to market. We’re a technology company that runs end-to-end clinical trials through a network of our own TrialSpark-operated trial sites, making the entire lifecycle of clinical trials more efficient, accessible, and patient-centric. We're growing quickly and would love to have you join us!

As population continues to age, there is a growing demand for motor rehabilitation services. The problem is that the way we address this growth or rehabilitation services (physical therapy) has not changed in thirty years because we are still heavily reliant on a one-to-one patient therapist interaction which is costly, non scalable, and difficult to ensure consistent quality. At SWORD Health, we saw the opportunity to take a truly disruptive and transformative approach to this problem by creating the first digital therapy solution that addresses the growing demand for therapy while reducing costs, empowering patients with their recovery to ultimately recover faster, and providing a rich source of data for clinical teams and decision makers. Video: vimeo.com/118489111

Triomics is revolutionizing the process of data management for clinical research by leveraging EHR interoperability and machine learning.

James Lind pioneered the first clinical trial in the 18th century, using oranges and lemons as a cure for scurvy. Like Lind, our mission is to improve health outcomes for all. Today clinical trials are slow, inefficient and hugely expensive. The result is that patients lose out on new treatments. Lindus Health will fix this. We're building the platform for the next generation of clinical trials.

Tempus is a technology company that has built an operating system to battle cancer. Tempus enables physicians to deliver personalized cancer care through its interactive analytical and machine learning platform. The company provides genomic sequencing services and analyzes molecular and therapeutic data to empower physicians to make real-time, data-driven decisions. Our goal is for each patient to benefit from the treatment of others who came before by providing physicians with tools that learn as we gather more data.

Altis Labs is the AI-powered computational imaging company advancing precision medicine. Trained on the world's largest cancer imaging database, our deep learning models predict outcomes to quantify treatment effect more accurately. Leading biopharmaceutical companies use our AI platform, Nota, to analyze clinical trial imaging data in a more meaningful way, allowing them to develop effective novel therapies faster. Founded in 2019, Altis is a venture-backed company headquartered in Toronto. We are actively growing our team in Canada and the US across functional areas.

Castor is a cloud-based data solution, enabling medical researchers to easily capture and integrate data from any source. Thousands of medical device, biotech and academic researchers around the world are using Castor EDC (Electronic Data Capture), eCRF, ePRO, eCOA, and eTMF to accelerate their studies. Our long-term vision reaches even further, and we are working towards a world in which: 1. Researchers can easily collaborate on similar projects 2. Diverse data sources can be linked easily, and at a small price 3. The inclusion of patients is efficient and simple, due to collaboration and smart usage of descriptive data

RDI is an overnight success — years in the making. We’re scaling fast (grew 4× last year), fueled by enterprise engagements with the top IVD manufacturers in the world. For a small team, we punch way above our weight. RDI has become the go-to CRO for large public diagnostics companies who rely on our creativity, tech-forward systems, and zero-excuses accountability to get trials done quickly and done right. We’re a fully integrated IVD CRO — a high-complexity CLIA lab, a technology-enabled CRO, and a national physician + lab network under one roof. This lets us run clinical trials with a level of speed and operational precision the industry isn’t used to. RDI was founded in 2008 and professionalized in 2017 through a search fund acquisition (not venture hype). We’re backed by long-term operators and growth investors — not dependent on VC burn or fundraising cycles. From 2022–2024, we expanded aggressively by doing the hard things right: building real infrastructure, earning trust from enterprise customers, and executing consistently. Our physician network was sourced from real insurance claims data and strengthened by CAP accreditation. No one has successfully started and scaled a modern CRO focused on diagnostics and medical devices in over 15 years. The industry is dominated by large, slow incumbents optimized for pharma — not speed, accountability, or precision. We’re the underdog — and we’re winning. Our goal is simple: prove our customers right, and prove the industry wrong. Get a feel for how we work: youtube.com/watch?v=3tccEbsWIl8

SiteRx is a data security control and quality system to ensure that data remains secure, reliable, and HIPAA-compliant. The products provide assistance in inpatient trials with the assistance of AI-based technology. They are specialized in healthcare information technology, artificial intelligence, natural language processing, machine learning, clinical trials, patient recruitment, and neurology.

Crescendo Health is an innovative digital health company whose mission is to accelerate clinical trials and medical innovation. Crescendo Health is transforming the way patient health data is collected and used to advance clinical research. Leveraging many of the same transformative technologies that have revolutionized patient care, Crescendo Health builds relationships with patients and curates the data for trial sponsors to have a more comprehensive and longitudinal view of patient health. Founded by veteran healthcare executives from Datavant and Grand Rounds, the Crescendo Health team includes leaders from across research, technology, academic and provider communities. The company was founded in 2021 and is backed by leading institutional and angel investors. The time has come to build a new generation of clinical trials that makes use of real world health data, so that new treatments can be developed quickly for those in need and trial evidence reflects the diversity of our population.